465 related articles for article (PubMed ID: 12626555)
1. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
[TBL] [Abstract][Full Text] [Related]
2. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
[TBL] [Abstract][Full Text] [Related]
3. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
4. Skin allograft maintenance in a new synchimeric model system of tolerance.
Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
[TBL] [Abstract][Full Text] [Related]
5. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
Ito H; Kurtz J; Shaffer J; Sykes M
J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
[TBL] [Abstract][Full Text] [Related]
6. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
Demirci G; Strom TB; Li XC
J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
[TBL] [Abstract][Full Text] [Related]
7. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
8. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
[TBL] [Abstract][Full Text] [Related]
9. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells.
Nasr IW; Wang Y; Gao G; Deng S; Diggs L; Rothstein DM; Tellides G; Lakkis FG; Dai Z
J Immunol; 2005 May; 174(10):6161-8. PubMed ID: 15879112
[TBL] [Abstract][Full Text] [Related]
10. Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice.
Pearson T; Markees TG; Serreze DV; Pierce MA; Marron MP; Wicker LS; Peterson LB; Shultz LD; Mordes JP; Rossini AA; Greiner DL
J Immunol; 2003 Jul; 171(1):185-95. PubMed ID: 12816997
[TBL] [Abstract][Full Text] [Related]
11. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways.
Nicolls MR; Coulombe M; Beilke J; Gelhaus HC; Gill RG
J Immunol; 2002 Nov; 169(9):4831-9. PubMed ID: 12391193
[TBL] [Abstract][Full Text] [Related]
12. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
[TBL] [Abstract][Full Text] [Related]
13. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
14. NOD mice have a generalized defect in their response to transplantation tolerance induction.
Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
[TBL] [Abstract][Full Text] [Related]
15. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
Fischbein MP; Ardehali A; Yun J; Schoenberger S; Laks H; Irie Y; Dempsey P; Cheng G; Fishbein MC; Bonavida B
J Immunol; 2000 Dec; 165(12):7316-22. PubMed ID: 11120867
[TBL] [Abstract][Full Text] [Related]
16. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms.
Forman D; Welsh RM; Markees TG; Woda BA; Mordes JP; Rossini AA; Greiner DL
J Immunol; 2002 Jun; 168(12):6047-56. PubMed ID: 12055213
[TBL] [Abstract][Full Text] [Related]
17. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
18. Rat xenograft survival in mice treated with donor-specific transfusion and anti-CD154 antibody is enhanced by elimination of host CD4+ cells.
Gordon EJ; Woda BA; Shultz LD; Rossini AA; Greiner DL; Mordes JP
Transplantation; 2001 Jan; 71(2):319-27. PubMed ID: 11213080
[TBL] [Abstract][Full Text] [Related]
19. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.
Gordon EJ; Kelkar V
Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653
[TBL] [Abstract][Full Text] [Related]
20. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models.
Rothstein DM; Livak MF; Kishimoto K; Ariyan C; Qian HY; Fecteau S; Sho M; Deng S; Zheng XX; Sayegh MH; Basadonna GP
J Immunol; 2001 Jan; 166(1):322-9. PubMed ID: 11123308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
